The price of EOLS is predicted to go up 4.43%, based on the high correlation periods with MIDD. The similarity of these two price pattern on the periods is 96.11%.
EOLS
MIDD
Up: 4.43%Similarity: 96.11%
EOLS Revenue Forecast
EOLS EPS Forecast
EOLS FAQs
What is EOLS revenue forecast for next quarter?
The market consensus for EOLS's revenue in the upcoming quarter is projected to be approximately $73.062M USD.
What is EOLS eps forecast for next quarter?
The market consensus for EOLS's eps in the upcoming quarter is projected to be approximately $0.10 USD.
Barclays analyst Balaji Prasad raised the firm's price target on Evolus to $25 from $22 and keeps an Overweight rating on the shares. The Evoylsse label includes weight-loss as a cause of facial wrinkles, which is a first and should enhance its GLP-1 related uptake, the analyst tells investors in a research note. The firm says this launch positions Evolus as a stronger competitor and aids in greater account penetration.